How to treat Lung cancer?

['Obi kel párti li']

Modi ki nu ta proteje di kankru di pulmon?

Tratamentu di kankru di pulmon ta dipende di txeu fatoris, sima stájiu di kankru, tipu di kankru di pulmon i saúdi jeral di duenti.

Alguns tratamentu di saúdi é:

1. Operason: txeu bês kel-li é tratamentu ki más ta uzadu pa kankru di pulmon.

Kel algen ta tra kel tumor i un párti pikinoti di tisidu pértu di el.

2. Terapia ku radiason: Radiason di txeu inerjia ta uzadu pa mata sélulas di kankru i pa diminui tumor.

El pode uzadu el sô ô djuntu ku otus tratamentu.

3. Kimioterapia: Kes tratamentu li ta uza medikamentu pa mata sélulas di kankru.

El pode uzadu pa intravenozu ô pa oralu, i txeu bês el ta uzadu djuntu ku otus tratamentu.

4. Terapia dizenhadu: Es tratamentu ta prujudika genes ô proteinas ki ta djuda sélulas di kankru kria i kontinua bibu.

Txeu bês el ta uzadu pa kankru di pulmon avansadu ô metastátiku.

5. Imunoterapia: Kel tratamentu li ta djuda sistema di imuniza algen i ta ataka sélulas di kankru.

Txeu bês el ta uzadu pa kankru di pulmon avansadu ô metastátiku.

6. Terapia fotodinâmiku: Kel tratamentu li ta uza un droga ativadu pa lus pa mata sélulas di kankru.

Txeu bês el ta uzadu pa kankru di pulmon na stadu di sédu.

7. Terapia ku proton: é un tipu di tratamentu ku radiason ki ta uza proton envês di raiu X pa da radiason pa tumor.

Txeu bês el ta uzadu pa kankru di pulmon na stadu di sédu.

8. Insaiu di un tratamentu: Kes algen ki sta duenti pode faze un insaiu di un tratamentu ô faze un konbinason di tratamentu.

É inportanti pâpia ku médikus sobri midjór tratamentu, pamodi midjór tratamentu ta dipende di situason di kada algen.

['Referénsia']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.

Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.

Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.

Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.

Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.

Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.

Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.

['Diskrison: médiku']

['Es site é sô pa studa i pa da informason.']

['Kes informason li ka debe uzadu pa faze diagnóstiku ô pa kura algun prubléma di saúdi.']

['Pur favor, toma nota ma redi neuronal ki ta jenera respóstas pa perguntas, é spesialmenti inakuradu óras ki ta papiadu di konteúdu numériku. Pur izénplu, nunbru di pesoas diagnostikadu ku un duénsa spesifiku.']

['Sénpri buska konsedju di bu médiku ó otu prestador di kuidadu di saúdi kualifikadu sobri un kondison médiku. Nunka ka bu nega konsedju di médiku profisional ô atrasa na buska-l pamodi algun kuza ki bu lé na es pájina. Si bu atxa ma bu pode ten un imerjénsia médiku, txoma 911 ô bai pa kuartu di imerjénsia más pértu imediatamenti.']

['Diskubri autor']

['Lei di Direitus Umanu Digital di 1998, 17 U.S.C. § 512 (o DMCA) ta dispunibiliza rikursus pa titular di direitus ki ta atxa ma material ki ta parsi na Internet ta viola ses direitus di akordu ku lei di direitus di autor di Stadus Unidus. ']

['Si bu kré, di bon fé, ki kualker kontiudu ô material disponibilizadu na nos site ô servisus ta viola bu direitus di autor, bo (ô bu ajenti) podi manda-nu un avizu ta pidi pa retiradu ô blokia es konteúdu ô material.']

['Nu ten ki manda un mensaji pa email (odja "Contact" pa kel email).']

['Es lei ta iziji ki bu notifikason di alegadu violason di copyright inklui kes siginti informason: (1) un deskripson di obra protejedu pa copyright ki e sujetu di alegadu violason; (2) un deskripson di kel konteúdu alegadu y informason sufisienti pa permiti-nu lokaliza kel konteúdu; (3) informason di kontatu pa bo, inkluindu bu enderesu, númeru di tilifon i enderesu di email; (4) un deklarason di bo ki ten un bon fé ma kel konteúdu di forma reklamadu ka e autorizadu pa donu di copyright, o pa se ajenti, o pa kualker lei; ']

['5. un deklarason di bu senhoriu, asinadu sob pena di perjúriu, ma informason na notifikason é izatu y ma bu ten autoridadi pa pratika kel direitu di autor ki foi violadu;']

['i (6) un asinatura fíziku ô iletróniku di kel algen ki é donu di direitus di autor ô di un algen ki sta autorizadu pa aji na se nómi.']

['Si bu ka da tudu informason, kel informason pode dimora txeu ténpu.']

['Kontaktu di Grupu']

['Pur favor, manda-nu email ku kalker pergunta/sugeston.']

How to treat lung cancer?

The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.

Some common treatment options include:

1. Surgery: This is often the preferred treatment for early-stage lung cancer.

The surgeon removes the tumor and a small portion of healthy tissue around it.

2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.

It can be used alone or in combination with other treatments.

3. Chemotherapy: This treatment uses drugs to kill cancer cells.

It can be given intravenously or or orally, and is often used in combination with other treatments.

4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.

It is often used for advanced or metastatic lung cancer.

5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.

It is often used for advanced or metastatic lung cancer.

6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.

It is often used for early-stage lung cancer.

7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.

It is often used for early-stage lung cancer.

8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.

It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.